ClinicalTrials.gov
public full text
Public Domain
Effect of Pycnogenol® on ADHD
This double blind, randomised controlled trial examines the effect of a commercially available nutritional supplement on behaviour of ADHD patients, as well as on their physical and psychiatric co-morbidities, and level of oxidative stress and immune activity, as compared to placebo and standard pharmaceutical treatment for ADHD.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications#905368
- Acute Effects of Stimulant Medication on Gray Matter and White Matter Indices in Healthy Controls and Adults With ADHD.#380683
- Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder#889305
- The Use of Lisdexamfetamine for Children Aged 7-13 With Attention Deficit Disorders#1161351
- Pharmacological Management of ADHD in Women Across Perimenopause, Menopause and Post-Menopause.#161866
Record · ID 1171038
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive